ReP USP - Resultado da busca

Artigo de periodico
The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis (2003)
Mabley, Jon; Soriano, Francisco; Pacher, Pál; Haskó, Gÿorgy; Marton, Anita; Wallace, Rebecca; Salzman, Andrew; Szabó, Csaba
Source: European Journal of Pharmacology,. Unidade: FM
Subjects: COLITE ULCERATIVA, RECEPTORES, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MABLEY, Jon et al. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. European Journal of Pharmacology, v. 466, p. 323-329, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0014-2999(03)01570-x. Acesso em: 08 set. 2024.
APA
Mabley, J., Soriano, F., Pacher, P., Haskó, G., Marton, A., Wallace, R., et al. (2003). The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. European Journal of Pharmacology,, 466, 323-329. doi:10.1016/s0014-2999(03)01570-x
NLM
Mabley J, Soriano F, Pacher P, Haskó G, Marton A, Wallace R, Salzman A, Szabó C. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis [Internet]. European Journal of Pharmacology,. 2003 ; 466 323-329.[citado 2024 set. 08 ] Available from: https://doi.org/10.1016/s0014-2999(03)01570-x
Vancouver
Mabley J, Soriano F, Pacher P, Haskó G, Marton A, Wallace R, Salzman A, Szabó C. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis [Internet]. European Journal of Pharmacology,. 2003 ; 466 323-329.[citado 2024 set. 08 ] Available from: https://doi.org/10.1016/s0014-2999(03)01570-x
Artigo de periodico
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents (2002)
Jagtap, Prakash; Soriano, Francisco Garcia; Virág, Lászlo; Liaudet, Lucas; Mabley, Jon; Szabó, Éva; Haskó, György; Marton, Anita; Lorigados, Clara Batista; Gallyas Junior, Ferenc; Sümegi, Ballázs; Hoyt, Dale G.; Baloglu, Erkan; VanDuzer, John; Salzman, Andrew L.; Southan, Garry J.; Szabó, Csaba
Source: Critical Care Medicine. Unidade: FM
Assunto: CLÍNICA GERAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAGTAP, Prakash et al. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents. Critical Care Medicine, v. 30, n. 5, p. 1071-1082, 2002Tradução . . Disponível em: https://doi.org/10.1097/00003246-200205000-00019. Acesso em: 08 set. 2024.
APA
Jagtap, P., Soriano, F. G., Virág, L., Liaudet, L., Mabley, J., Szabó, É., et al. (2002). Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents. Critical Care Medicine, 30( 5), 1071-1082. doi:10.1097/00003246-200205000-00019
NLM
Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó É, Haskó G, Marton A, Lorigados CB, Gallyas Junior F, Sümegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabó C. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents [Internet]. Critical Care Medicine. 2002 ; 30( 5): 1071-1082.[citado 2024 set. 08 ] Available from: https://doi.org/10.1097/00003246-200205000-00019
Vancouver
Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó É, Haskó G, Marton A, Lorigados CB, Gallyas Junior F, Sümegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabó C. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents [Internet]. Critical Care Medicine. 2002 ; 30( 5): 1071-1082.[citado 2024 set. 08 ] Available from: https://doi.org/10.1097/00003246-200205000-00019
Trabalho de evento-resumo periodico
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation (2001)
Soriano, Francisco Garcia; Virág, Lászlo; Jagtap, Prakash; Szabó, Éva; Mabley, Jon; Liaudet, Lucas; Marton, Anita; Salzman, Andrew L.; Szabó, Csaba
Source: The Faseb Journal. Conference titles: Experimental Biology. Unidade: FM
Subjects: MEDICINA, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORIANO, Francisco Garcia et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. The Faseb Journal. Seattle: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 set. 2024. , 2001
APA
Soriano, F. G., Virág, L., Jagtap, P., Szabó, É., Mabley, J., Liaudet, L., et al. (2001). Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. The Faseb Journal. Seattle: Faculdade de Medicina, Universidade de São Paulo.
NLM
Soriano FG, Virág L, Jagtap P, Szabó É, Mabley J, Liaudet L, Marton A, Salzman AL, Szabó C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. The Faseb Journal. 2001 ; 15( 4): A215.[citado 2024 set. 08 ]
Vancouver
Soriano FG, Virág L, Jagtap P, Szabó É, Mabley J, Liaudet L, Marton A, Salzman AL, Szabó C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. The Faseb Journal. 2001 ; 15( 4): A215.[citado 2024 set. 08 ]
Trabalho de evento-resumo periodico
Cytoprotective effects of novel phenanthridinone inhibitors of poly (ADP-ribose) polymerase (2001)
Virag, Laszlo; Liaudet, Lucas; Szabo, Csaba; Jagtap, Prakash; Mabley, Jon; Szabo, Eva; Hasko,Gyorgy; Hoyt, Dale; Salzman, Andrew; Southan, Garry; Soriano, Francisco Garcia
Source: The Faseb Journal. Conference titles: Experimental Biology. Unidade: FM
Assunto: BIOLOGIA EXPERIMENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIRAG, Laszlo et al. Cytoprotective effects of novel phenanthridinone inhibitors of poly (ADP-ribose) polymerase. The Faseb Journal. Seattle, Washington: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 set. 2024. , 2001
APA
Virag, L., Liaudet, L., Szabo, C., Jagtap, P., Mabley, J., Szabo, E., et al. (2001). Cytoprotective effects of novel phenanthridinone inhibitors of poly (ADP-ribose) polymerase. The Faseb Journal. Seattle, Washington: Faculdade de Medicina, Universidade de São Paulo.
NLM
Virag L, Liaudet L, Szabo C, Jagtap P, Mabley J, Szabo E, Hasko G, Hoyt D, Salzman A, Southan G, Soriano FG. Cytoprotective effects of novel phenanthridinone inhibitors of poly (ADP-ribose) polymerase. The Faseb Journal. 2001 ; 15( 5): A567.[citado 2024 set. 08 ]
Vancouver
Virag L, Liaudet L, Szabo C, Jagtap P, Mabley J, Szabo E, Hasko G, Hoyt D, Salzman A, Southan G, Soriano FG. Cytoprotective effects of novel phenanthridinone inhibitors of poly (ADP-ribose) polymerase. The Faseb Journal. 2001 ; 15( 5): A567.[citado 2024 set. 08 ]
Artigo de periodico
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of Poly (ADP-Ribose) Polymerase (2001)
Soriano, Francisco Garcia; Pacher, Pál; Mabley, Jon; Liaudet, Lucas; Szabó, Csaba
Source: Circulation Research. Unidade: FM
Subjects: DIABETES MELLITUS, ENDOTÉLIO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORIANO, Francisco Garcia et al. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of Poly (ADP-Ribose) Polymerase. Circulation Research, p. 684-691, 2001Tradução . . Acesso em: 08 set. 2024.
APA
Soriano, F. G., Pacher, P., Mabley, J., Liaudet, L., & Szabó, C. (2001). Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of Poly (ADP-Ribose) Polymerase. Circulation Research, 684-691.
NLM
Soriano FG, Pacher P, Mabley J, Liaudet L, Szabó C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of Poly (ADP-Ribose) Polymerase. Circulation Research. 2001 ; 684-691.[citado 2024 set. 08 ]
Vancouver
Soriano FG, Pacher P, Mabley J, Liaudet L, Szabó C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of Poly (ADP-Ribose) Polymerase. Circulation Research. 2001 ; 684-691.[citado 2024 set. 08 ]
Trabalho de evento-resumo periodico
Essential role of NF-kB (p50) in the development of type I diabetes (2001)
Mabley, Jon; Soriano, Francisco Garcia; Hasko, Gearge; Liaudet, Lucas; Salzman, Andrew L.; Szabó, Csaba; Southan, Garry
Source: The Faseb Journal. Conference titles: Experimental Biology. Unidade: FM
Subjects: MEDICINA, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MABLEY, Jon et al. Essential role of NF-kB (p50) in the development of type I diabetes. The Faseb Journal. Seattle: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 set. 2024. , 2001
APA
Mabley, J., Soriano, F. G., Hasko, G., Liaudet, L., Salzman, A. L., Szabó, C., & Southan, G. (2001). Essential role of NF-kB (p50) in the development of type I diabetes. The Faseb Journal. Seattle: Faculdade de Medicina, Universidade de São Paulo.
NLM
Mabley J, Soriano FG, Hasko G, Liaudet L, Salzman AL, Szabó C, Southan G. Essential role of NF-kB (p50) in the development of type I diabetes. The Faseb Journal. 2001 ; 15( 4): A216.[citado 2024 set. 08 ]
Vancouver
Mabley J, Soriano FG, Hasko G, Liaudet L, Salzman AL, Szabó C, Southan G. Essential role of NF-kB (p50) in the development of type I diabetes. The Faseb Journal. 2001 ; 15( 4): A216.[citado 2024 set. 08 ]
Trabalho de evento-resumo periodico
Role of poly(ADP-ribose) polymerase activation in the pathogenesis of endothelial injury induced by high glucose in vitro (2001)
Virag, Laszlo; Soriano, Francisco Garcia; Jagtap, Prakash; Szabó, Éva; Mabley, Jon; Liaudet, Lucas; Salzman, Andrew L.; Szabó, Csaba; Southan, Garry; Murthy, Kanneganti; Hoyt, Dale
Source: The Faseb Journal. Conference titles: Experimental Biology. Unidade: FM
Assunto: MEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIRAG, Laszlo et al. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of endothelial injury induced by high glucose in vitro. The Faseb Journal. Seattle: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 set. 2024. , 2001
APA
Virag, L., Soriano, F. G., Jagtap, P., Szabó, É., Mabley, J., Liaudet, L., et al. (2001). Role of poly(ADP-ribose) polymerase activation in the pathogenesis of endothelial injury induced by high glucose in vitro. The Faseb Journal. Seattle: Faculdade de Medicina, Universidade de São Paulo.
NLM
Virag L, Soriano FG, Jagtap P, Szabó É, Mabley J, Liaudet L, Salzman AL, Szabó C, Southan G, Murthy K, Hoyt D. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of endothelial injury induced by high glucose in vitro. The Faseb Journal. 2001 ; 15( 4): A216.[citado 2024 set. 08 ]
Vancouver
Virag L, Soriano FG, Jagtap P, Szabó É, Mabley J, Liaudet L, Salzman AL, Szabó C, Southan G, Murthy K, Hoyt D. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of endothelial injury induced by high glucose in vitro. The Faseb Journal. 2001 ; 15( 4): A216.[citado 2024 set. 08 ]
Artigo de periodico
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation (2001)
Soriano, Francisco Garcia; Virág, Lászlo; Jagtap, Prakash; Szabó, Éva; Mabley, Jon; Liaudet, Lucas; Marton, Anita; Hoyt, Dale G.; Murthy, Kanneganti G. K.; Salzman, Andrew L.; Southan, Garry J.; Szabó, Csaba
Source: Nature Medicine. Unidade: FM
Subjects: MEDICINA, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORIANO, Francisco Garcia et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nature Medicine, v. 7, n. ja 2001, p. 108-113, 2001Tradução . . Disponível em: https://doi.org/10.1038/83241. Acesso em: 08 set. 2024.
APA
Soriano, F. G., Virág, L., Jagtap, P., Szabó, É., Mabley, J., Liaudet, L., et al. (2001). Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nature Medicine, 7( ja 2001), 108-113. doi:10.1038/83241
NLM
Soriano FG, Virág L, Jagtap P, Szabó É, Mabley J, Liaudet L, Marton A, Hoyt DG, Murthy KGK, Salzman AL, Southan GJ, Szabó C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation [Internet]. Nature Medicine. 2001 ; 7( ja 2001): 108-113.[citado 2024 set. 08 ] Available from: https://doi.org/10.1038/83241
Vancouver
Soriano FG, Virág L, Jagtap P, Szabó É, Mabley J, Liaudet L, Marton A, Hoyt DG, Murthy KGK, Salzman AL, Southan GJ, Szabó C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation [Internet]. Nature Medicine. 2001 ; 7( ja 2001): 108-113.[citado 2024 set. 08 ] Available from: https://doi.org/10.1038/83241

USP Schools

ReP

Filtros

Authors

Subjects